Potential Psychiatric Uses for MDMA
Clinical Pharmacology & Therapeutics November 10, 2016 Bb Yazar‐klosinski, Mc Mithoefer 81 citations
Phase II trials of 3,4‐methylenedioxymethamphetamine (MDMA)‐assisted psychotherapy have demonstrated initial safety and efficacy for treatment of posttraumatic stress disorder (PTSD), with potential for expansion to depression and anxiety disorders. In these trials, single doses of MDMA are administered in a model of medication‐assisted psychotherapy, differing from trials involving daily drug...
DOI: 10.1002/cpt.565 (opens in new tab)
MDMA-Assisted Psychotherapy
PTSD Treatment
Mental health innovation
Regulatory pathways